Eiger Biopharmaceuticals Inc ()

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Propel Bio Management

Leen Kawas And Richard Kayne

4,391,432 $985,876 0.81%
2. 2,100,000 $471,450 -21% 0.03%
3.
Millennium Management

Israel Englander

81,144 $18,217 -70% 0%
4. 14,478 $3,250 0%
5. 10,008 $2,247 0%
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 7,505,539 $1,684,993 0%
2. 1,820,767 $408,762 0%
3. 583,730 $131,048 0%
4. 379,707 $85,267 0%
5. 338,733 $76,046 0%
News See All